Tg Therapeutics, Inc. · NASDAQ:TGTX
Vanguard Portfolio Management LLC reported a 5.26% stake in Tg Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 29, 2026
Vanguard Portfolio Management LLC reported a 5.26% stake in Tg Therapeutics, Inc., 8,400,210 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.26%
- Shares
- 8,400,210
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Portfolio Management | 5.26% | 8,400,210 |
Source
Related
- Tg Therapeutics, Inc.
- Vanguard Portfolio Management LLC
- Tg Therapeutics, Inc. shareholders
- Form 4 · Charney Laurence N · Sep 14, 2026
- Form 4 · Charney Laurence N · Aug 7, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G · State Street Corp · Nov 10, 2025
- Schedule 13G · State Street Corp · May 13, 2025